Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/8/2006
 
First Published:
6/1/2001
1.
Phase III Randomized Study of Paclitaxel and Carboplatin With Versus Without ISIS 3521 in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
Pharmaceutical / Industry
ISIS-3521-CS17
CWRU-040123, ISIS-1501, NCT00017407
Last Modified:
10/13/2006
 
First Published:
3/1/1998
2.
Phase II Study of ISIS 3521 in Patients with Refractory or Recurrent High Grade Astrocytomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
NABTT-9706
JHOC-NABTT-9706
Last Modified:
5/17/2007
 
First Published:
4/1/1998
3.
Phase II Randomized Study of ISIS 5132 or ISIS 3521 in Women With Previously Treated Metastatic Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
ECOG-3197
NCT00003236, E3197
Last Modified:
7/1/1999
 
First Published:
8/1/1998
4.
Phase II Randomized Study of ISIS 3521 and ISIS 5132 in Patients with Hormone Refractory Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
CAN-NCIC-IND111
IND111
Last Modified:
12/1/1999
 
First Published:
8/1/1998
5.
Phase II Randomized Study of ISIS 3521 and ISIS 5132 for Locally Advanced or Metastatic Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
CAN-NCIC-IND112
IND112
Last Modified:
5/1/2000
 
First Published:
9/1/1999
6.
Phase II Study of ISIS 3521 in Patients with Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer or Unresectable or Metastatic Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
EORTC-16977
ISIS-EORTC-16977, NCT00003989
Last Modified:
4/1/2002
 
First Published:
4/1/2002
7.
Phase II Study of ISIS 3521 in Patients With Previously Treated, Low-Grade Non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCLA-000808401
ISIS-3521-CS18, NCI-G02-2056
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute